We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+11%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.83B
AUM Growth
+$439M
(+6.9%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
26.62%
Holding
140
New
27
Increased
39
Reduced
39
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$127M |
| 2 |
AnaptysBio
ANAB
|
+$76M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$62.1M |
| 4 |
TSMC
TSM
|
+$59.5M |
| 5 |
LKQ Corp
LKQ
|
+$45.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$89.2M |
| 2 |
Centene
CNC
|
+$80.2M |
| 3 |
HOLX
Hologic
HOLX
|
+$75.2M |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
+$65.8M |
| 5 |
Baxter International
BAX
|
+$63.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.61% |
| 2 | Technology | 13.09% |
| 3 | Communication Services | 5.22% |
| 4 | Consumer Discretionary | 2.37% |
| 5 | Financials | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
101
Autolus Therapeutics
AUTL
$407M
| $6.74M | 0.1% |
219,628
+21,754
| +11% | +$587K |
|
102
Tenable Holdings
TENB
$3.6B
| $5.41M | 0.08% |
+139,242
| New | +$4.63M |
|
103
MongoDB
MDB
$27.1B
| $5.08M | 0.07% |
+62,326
| New | +$4.15M |
|
|
CBLK
104
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $4.9M | 0.07% |
231,286
-3,041
| -1% | -$71.4K |
|
|
ECYT
105
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $4.16M | 0.06% |
234,378
-3,834,230
| -94% | -$65.8M |
|
|
CMTA
106
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $3.6M | 0.05% |
322,732
| – | – |
|
|
EB
107
DELISTED
Eventbrite
EB
| $2.22M | 0.03% |
+58,441
| New | +$2.11M |
|
108
Zscaler
ZS
$24.5B
| $1.91M | 0.03% |
46,814
| – | – |
|
|
DOCU
109
DocuSign
DOCU
$10.5B
| $1.01M | 0.01% |
19,199
| – | – |
|
110
Agios Pharmaceuticals
AGIO
$1.79B
| – | – |
-614,506
| Closed | -$51.8M |
|
111
CALL
Alibaba
BABA
$293B
| – | – |
-156,000
| Closed | -$28.9M |
|
|
112
Baxter International
BAX
$13.5B
| – | – |
-865,121
| Closed | -$63.9M |
|
|
113
Baidu
BIDU
$37.7B
| – | – |
-367,146
| Closed | -$89.2M |
|
114
Box
BOX
$4.37B
| – | – |
-50,359
| Closed | -$1.26M |
|
|
115
Centene
CNC
$30.7B
| – | – |
-1,302,436
| Closed | -$80.2M |
|
116
CALL
DaVita
DVA
$15.4B
| – | – |
-420,400
| Closed | -$29.2M |
|
117
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| – | – |
-3,005,700
| Closed | -$130M |
|
|
HOLX
118
DELISTED
Hologic
HOLX
| – | – |
-1,892,703
| Closed | -$75.2M |
|
119
PUT
Heron Therapeutics
HRTX
$93.9M
| – | – |
-1,777,500
| Closed | -$69.1M |
|
120
ServiceNow
NOW
$115B
| – | – |
-24,340
| Closed | -$840K |
|
121
PagSeguro Digital
PAGS
$2.69B
| – | – |
-337,283
| Closed | -$9.36M |
|
122
PUT
Invesco QQQ Trust
QQQ
$453B
| – | – |
-2,398,900
| Closed | -$412M |
|
123
S&P Global
SPGI
$121B
| – | – |
-201,114
| Closed | -$41M |
|
124
Trip.com Group
TCOM
$29.6B
| – | – |
-826,224
| Closed | -$39.4M |
|
125
Teleflex
TFX
$6.05B
| – | – |
-169,796
| Closed | -$45.5M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
YL
PFM Health Sciences's Q3 2018 Portfolio in Review
As of Q3 2018, PFM Health Sciences held 140 positions worth $6.83B, up 6.9% from $6.39B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
PFM Health Sciences withdrew a net $277M in Q3 2018, closing 23 positions and reducing 39 holdings. Its most notable exit was Baidu, an estimated $89.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.
Against the trend, PFM Health Sciences opened a new position in Allergan plc worth $131M.
- PFM Health Sciences's largest Q3 2018 buy was Allergan plc: 689,949 shares worth $131M.
- PFM Health Sciences added most to AnaptysBio in Q3 2018, an estimated $76M increase.
- PFM Health Sciences's biggest Q3 2018 reduction was Endocyte, Inc. Common Stock, cutting an estimated $65.8M.
- PFM Health Sciences fully exited Baidu in Q3 2018, selling an estimated $89.2M.
- PFM Health Sciences's ten largest holdings make up 27% of its $6.83B portfolio in Q3 2018.
- PFM Health Sciences opened 27 new positions and closed 23 in Q3 2018.
- PFM Health Sciences's portfolio value rose 6.9% quarter-over-quarter to $6.83B.
Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.